Adherium (ASX:ADR) says it will be exhibiting and meeting with commercial partners at the American Academy of Allergy, Asthma and Immunology’s 2024 Annual Meeting in Washington.
The company is a leader in respiratory eHealth, remote monitoring and data management solutions.
It said its booth will feature live demonstrations of the Hailie platform that enables remote monitoring of adherence and physiological parameters such as inspiratory flow.
Adherium said it will aim to further strengthen its partnerships with key health system providers and asthma medical groups, in alignment with its plan to service large patient populations in the US and other key international health markets.
CEO Dr Paul Mastoridis said, “Our team is excited to be attending and demonstrating our unique digital adherence system at the AAAAI 2024 Annual Meeting – an important meeting of our valued industry peers, fellow innovators, and customers too. Our Hailie platform system helps reduce emergency room visits, hospitalisations, exacerbations as well as healthcare costs associated with asthma and COPD. Our unique technology is of key interest to leading international medical experts who will be attending this event.”